The authors also showed that the addition of ATR inhibitor to an anti-PDL1 radioimmunotherapy program produced a cGAS-STING-dependent synergistic effect with increased infiltration, proliferation, and IFN-γ production from tumor infiltrating CD8+ T cells, as well as decreased numbers of tumor resident Tregs and exhausted T cells. Here, ATR is linked to neoplasm.